Digital Biomarkers represent a cutting-edge frontier in healthcare and medical research, offering a revolutionary approach to monitoring and assessing health using digital technologies. These biomarkers are quantifiable, objective, and measurable indicators derived from various digital sources, such as wearable devices, mobile apps, and sensors. Unlike traditional biomarkers, digital biomarkers capture real-time, continuous data, providing a dynamic and comprehensive view of an individual's health. The utilization of digital biomarkers spans a wide range of applications, including disease monitoring, drug development, and personalized healthcare. Wearable devices, for instance, can track physiological parameters, activity levels, and sleep patterns, offering valuable insights into a person's well-being. The real-time nature of digital biomarkers enables timely intervention and personalized treatment strategies. As digital biomarkers continue to evolve, they hold the promise of transforming healthcare by providing a more holistic and proactive approach to monitoring health, facilitating preventive strategies, and improving overall patient outcomes.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia